0001193125-11-200435.txt : 20110728 0001193125-11-200435.hdr.sgml : 20110728 20110728131957 ACCESSION NUMBER: 0001193125-11-200435 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110728 DATE AS OF CHANGE: 20110728 EFFECTIVENESS DATE: 20110728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHN HANCOCK LIFE INSURANCE CO (USA) SEPARATE ACCOUNT N CENTRAL INDEX KEY: 0000813572 IRS NUMBER: 232030787 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 333-152409 FILM NUMBER: 11992776 BUSINESS ADDRESS: STREET 1: 200 BLOOR STREET EAST ST 10 STREET 2: TORONTO M4W 1EF CITY: ONTARIO CANADA STATE: A6 ZIP: 48304 BUSINESS PHONE: 4169266302 MAIL ADDRESS: STREET 1: P O BOX 600 CITY: BUFFALO STATE: NY ZIP: 14201-0600 FORMER COMPANY: FORMER CONFORMED NAME: MANUFACTURERS LIFE INS CO USA SEPARATE ACCOUNT N DATE OF NAME CHANGE: 20020411 FORMER COMPANY: FORMER CONFORMED NAME: SEPARATE ACCOUNT FOUR OF THE MANUFACTURERS LIFE INS CO OF AM DATE OF NAME CHANGE: 19920703 0000813572 S000009940 JOHN HANCOCK LIFE INSURANCE CO (USA) SEPARATE ACCOUNT N C000069370 Corporate VUL 497 1 d497.htm JHUSA N - CVUL 09 JHUSA N - CVUL 09

Supplement to dated July 28, 2011 to

Prospectuses Dated May 2, 2011

 

 

This supplement is intended for distribution with prospectuses dated May 2, 2011 for variable life insurance contracts issued by John Hancock Life Insurance Company (U.S.A.) and John Hancock Life Insurance Company of New York, as applicable. The affected prospectuses bear the titles:

 

Accumulation VUL

Corporate VUL

Protection Variable Universal Life

Survivorship Variable Universal Life

  

Majestic Performance VUL

Majestic VULX

Majestic Survivorship VULX

Majestic VCOLIX

M International Equity portfolio

Effective June 17, 2011 Northern Cross, LLC replaced Brandes Investment Partners, L.P. as the subadviser of the M International Equity portfolio. In addition to this subadviser change, the management fee increased from 0.65% to 0.70% of the portfolio’s average daily net assets.

Portfolio Annual Expenses

In connection with the above-referenced subadviser change to the M International Equity portfolio, we amend and restate the fees and expenses and associated footnote for this portfolio contained in the Portfolio Annual Expenses table of your prospectus as follows:

 

Portfolio

  

Management
Fees

 

12b-1
Fees

 

Other
Expenses

 

Acquired Fund Fees and
Expenses

 

Total Operating
Expenses

M International Equity 9

   0.70%   0.00%   0.23%   0.00%   0.93%

 

9 Until April 30, 2012, M Financial Investment Advisers, Inc., the adviser to the portfolios, has contractually agreed to reimburse each portfolio for any ordinary expenses (other than advisory fees, brokerage or other portfolio transaction expenses or expenses for litigation, indemnification, taxes or other extraordinary expenses) to the extent that such expenses exceed 0.25% of the portfolio’s annualized daily average net assets. The fees shown in the table do not reflect this expense reimbursement. If this expense reimbursement had been reflected, the net Total Operating Expenses for the portfolios would be as indicated below. For more information, please refer to the prospectus for the underlying portfolios.

 

Portfolio

  

Total Operating Expenses

M Business Opportunity Value    0.88%
M Capital Appreciation    1.10%
M International Equity    0.93%
M Large Cap Growth    0.83%

Table of Investment Options and Investment Subadvisers

We amend and restate the following disclosure under the Table of Investment Options and Investment Subadvisers to reflect the
above-referenced subadviser change:

 

Portfolio

  

Portfolio Manager

  

Investment Objective

M International Equity

(a series of M Fund, Inc.)

   Northern Cross, LLC    To seek long-term capital appreciation through investment in equity securities of foreign issuers, including common stocks, and securities that are convertible into common stocks.

You should read this supplement together with the prospectus for the M Funds, Inc. dated April 29, 2011, as supplemented, for the contract you purchased, and retain both for future reference.

Prior to making any investment decisions, you should carefully review your product prospectus and all applicable supplements. In addition, you should review the prospectuses and applicable supplements for the underlying portfolios that we make available as investment options under the policies. The prospectuses describe the investment objectives, policies and restrictions of, and the risks relating to, investment in the portfolios. In the case of any of the portfolios that are operated as feeder funds, you should also review the prospectus for the corresponding master fund. If you need to obtain additional copies of any of these documents, please contact your representative or contact our Service Office at the address or telephone number on the back page of your product prospectus.

VLI ProdSupp VL1-MFunds 07/2011

 

1